Artia Global Partners »

Alkermes shares owned by Artia Global Partners

Quarter-by-quarter ownership of Alkermes (ALKS) shares owned by Artia Global Partners from 13F filings

Historical chart of Artia Global Partners investment in Alkermes

Tip: Access up to 7 years of quarterly data

All positions including Alkermes held by Artia Global Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alkermes by Artia Global Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $24M 449k 52.40

More positions owned by Artia Global Partners

Abivax Sa Sponsored Ads (ABVX)
Insmed Com Par $.01 (INSM)
Trevi Therapeutics (TRVI)
Brightspring Health Svcs (BTSG)
Revolution Medicines (RVMD)
Argenx Se Sponsored Adr (ARGX)
Alkermes SHS (ALKS)
Travere Therapeutics (TVTX)
Astrazeneca Ord (AZN)
Newamsterdam Pharma Company Ordinary Shares (NAMS)
Dianthus Therapeutics (DNTH)
Spdr Series Trust St Str Sp Biot (XBI)
Quest Diagnostics Incorporated (DGX)
Ionis Pharmaceuticals (IONS)
Eyepoint Com New (EYPT)

View all positions for Artia Global Partners

Top funds holding Alkermes

BlackRock
Baker Bros. Advisors
Vanguard Portfolio Management
State Street Corporation
Vanguard Capital Management
Renaissance Technologies
T. Rowe Price Associates
Geode Capital Management
Dimensional Fund Advisors
Deep Track Capital
American Century Companies
Holocene Advisors
Commodore Capital
Wellington Management Company
PRIMECAP Management Company

View all funds holding Alkermes